Sentences with phrase «than other products on»

Commercial refrigerators that earn the ENERGY STAR today are, on average, 20 percent more energy efficient than other products on the market... but that's only part of the story.

From the start, Teri saw going natural as the smart choice and placed an importance on developing products that are equal or better than other products on the market, but are made using all - natural ingredients.

You'll pay a bit more for this food than some other products on the market.

That product is about 20 percent less expensive than the other products on the market, and it works just as well, if not better.

Not only did it lift scratches and swirls from the targeted area on the body panel better than the other products on test, it also left the smartest finish on the paintwork, offering a shiny, polished appearance.

And at under $ 10 each, they are much less expensive than other products on the market.

Full disclosure: This product is more expensive than other products on the market — you definitely pay for the quality.

Resveratrol - Forte by Enzymatic Therapys is strong - it contains up to 8 times more trans - resveratrol than other products on the market!

Resveratrol - forte by Enzymatic Therapys is strong - it contains up to 8 times more trans - resveratrol than other products on the market!

For a knife that's a little different than the other products on this list, check out the Gerber Vital Skin and Gut Knife.

This is a smaller model than the other products on our list.

It is thicker than other products on the market, and very absorbent.

First, the belt and buckle strap that goes around the waist is much larger than every other product on our list.

Research suggests that D - aspartic could enhance testosterone production by over 45 % in a matter of weeks — and TestoGen has more of it per serving than any other product on the market.

SEATTLE, Apr 11, 2011 (BUSINESS WIRE)--(NASDAQ: AMZN)-- Millions of people are reading on Kindle, Kindle has more 5 - star reviews than any other product on Amazon, and in just five months the latest - generation Kindle became the bestselling product in the 16 - year history of Amazon.com.

Paperless Workflow ® fills this requirement better than any other product on the market today, handling everything including scanning and imaging, automated notifications, document profiling, routing, and emailing.

In 2014, indexed universal life grew faster than any other product on the individual life insurance market.

The TP - Link Smart Wi - Fi Light Switch makes putting multiple Wi - Fi light switches in your home slightly more affordable than any other product on our list.

Amazon struck the jackpot with record sales of its Echo Dot mass market smart speaker — which sold better than any other product on offer from all manufacturers and across all categories — after it slashed its already low price from $ 49.99 to $ 34.99.

Not exact matches

And I think they're just of a different generation, a different segment of humanity,» he said, mentioning that he felt Sacca and Mark Cuban understood the products better than others on the panel.

Budget 2016 also announces the Government's intention to launch public consultations on eliminating tariffs on food manufacturing ingredients other than supply - managed products.

In other words, if the company notices a shift in local consumer tastes, it can fire off a batch of new garb from a nearby factory and get product on shelves many months faster than the old way — a supply chain triumph given that Levi works two years in advance and uses more than 1,000 different finishes in a season, which lasts six months.

They came in with a product the Sharks didn't understand and tried to raise at a valuation higher than any other company to appear on Shark Tank ever had.

The picnic - ready frozen drink machine was a hit at outdoor parties — and it inspired a product that, as of today, has raised more money on crowdfunding site Kickstarter than any other product ever.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

The lengthy research cited on HVMN's website and others are primarily animal studies, rather than human studies, and primarily test one of two compounds in combination, rather than the half - dozen contained in a product like SPRINT.

One is to downsize and focus on just a few product areas, rather than attempting to compete with practically every other retailer in Canada.

If your product is faster, bigger or smaller, or comes in more colors, sizes and configurations than others on the market, you have a powerful selling strength.

Among the other lessons learned in the Lean LaunchPad class for healthcare, Blank says, were: It's better to focus on one product and target market rather than trying to do everything right out of the gate.

From integrating e-learning directly into the platform, to opening up its own freelance marketplace, thus making it easier than ever to sell products and services to other professionals directly on the site, LinkedIn is realizing a vision of handling almost every element imaginable in the professional workplace.

When pressed on the details of how the product works, Putnam declined to explain other than to say the device is a full - length mirror with an LCD display, surround - sound speakers, camera, and a microphone.

Customer loyalty measures something more than satisfaction — it measures whether someone is willing to put their name on the line and recommend your product or service to others or if they are willing to stick with your product / service in spite of an occasional poor experience.

At the product level, you need to be «better than any other product out on the market, otherwise, why are you there?»

Billionaire investor William Ackman in 2012 claimed the company was running a pyramid scheme, recruiting members with a promise of payment for enrolling others in distribution, rather than depending on the actual sale of its nutritional supplements and weight management products.

Its brand has become synonymous with Kleenex and other household products when it comes to fighting deadly allergies; in fact, the EpiPen enjoys a near - monopoly on the market with annual sales of more than $ 1.3 billion and nearly 90 % U.S. market share in the space.

And the products also offer other Alexa features, like smart home control, shopping, and more — think of it as an Alexa device mounted on your wall, rather than a stand - alone speaker.

Vaynerchuk admits that he's «betting on the jockey a lot of times»; in other words, the product itself is less important than the person who pitched it.

One other worrying element on its Q2 income statement is its cost of revenue for subscriptions which, at 34 %, is substantially higher than the same cost for products at 4.6 %.

The logic generally proceeds as follows: Because people are more likely to embark on road trips during a long weekend than at other times, gas station owners know demand for their product will rise.

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports»).

Instead, choose to acknowledge the uncomfortable reality that your product comes with a premium price, and use that as an opportunity to explain why it's significantly better than other options on the market.

LeapFrog's first fund of $ 135 million made equity investments of between $ 5 million and $ 15 million in eight companies in Africa and Asia offering insurance and other financial products to individuals living on less than $ 10 per day.

Benchmark partner Peter Fenton says he was attracted to a product that seemed easier to use and less expensive than others on the market.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In the final stage, companies embrace a hybrid business model and reallocate revenue streams to optimize for total value creation and capture rather than focusing on one — the product or the platform — at the expense of the other.

Another report from the Commerce Department showed new orders for U.S. - made goods rose more than expected in March, boosted by strong demand for transportation equipment and a range of other products, but business spending on equipment appeared to be slowing.

Then, on top of that, you increasingly have brand advertising dollars — also an order of magnitude more than direct response dollars — looking for somewhere to go other than TV, and it just so happens that Facebook is the perfect brand advertising platform.2 The company has the right set of products in the right market at the right time.

On some measures, and in some products, Australian markets are smaller than others in the Asian region, but nonetheless, at the height of the Asian and Russian crises, overseas banks chose to operate in Australia to cover positions established in Asian markets because liquidity in those markets was inadequate at the time.

Factors that could cause actual results to differ materially from those expressed or implied in any forward - looking statements include, but are not limited to: changes in consumer discretionary spending; our eCommerce platform not producing the anticipated benefits within the expected time - frame or at all; the streamlining of the Company's vendor base and execution of the Company's new merchandising strategy not producing the anticipated benefits within the expected time - frame or at all; the amount that we invest in strategic transactions and the timing and success of those investments; the integration of strategic acquisitions being more difficult, time - consuming, or costly than expected; inventory turn; changes in the competitive market and competition amongst retailers; changes in consumer demand or shopping patterns and our ability to identify new trends and have the right trending products in our stores and on our website; changes in existing tax, labor and other laws and regulations, including those changing tax rates and imposing new taxes and surcharges; limitations on the availability of attractive retail store sites; omni - channel growth; unauthorized disclosure of sensitive or confidential customer information; risks relating to our private brand offerings and new retail concepts; disruptions with our eCommerce platform, including issues caused by high volumes of users or transactions, or our information systems; factors affecting our vendors, including supply chain and currency risks; talent needs and the loss of Edward W. Stack, our Chairman and Chief Executive Officer; developments with sports leagues, professional athletes or sports superstars; weather - related disruptions and seasonality of our business; and risks associated with being a controlled company.

Kretchmer went to work on the product, social media software for publishers and brands, and when Kalanick thought it had progressed enough, he made 45 introductions to other angel investors in less than a week and agreed to invest in the company himself.